Market Tracker

07/31 10:01pm ET

Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

135.00
Delayed Data
As of Jul 31
 -0.46 / -0.34%
Today’s Change
84.41
Today|||52-Week Range
137.50
+13.64%
Year-to-Date

Today’s Trading

Previous close135.46
Today’s open134.89
Day’s range133.02 - 136.00
Volume1,545,982
Average volume (3 months)1,548,409
Market cap$31.3B
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)-58.59%
Earnings growth (this year)+38.74%
Earnings growth (next 5 years)+19.00%
Revenue growth (last year)-52.11%
P/E ratioNM
Price/Sales48.16
Price/Book28.85

Competitors

 Today’s
change
Today’s
% change
PRGOPerrigo Company PLC+0.77+0.40%
MYLMylan NV-0.36-0.64%
ZTSZoetis Inc+0.43+0.89%
BMRNBiomarin Pharmaceuti...+1.71+1.18%
Data as of 4:14pm ET, 07/31/2015

Financials

Next reporting dateOctober 26, 2015
EPS forecast (this quarter)-$0.49
Annual revenue (last year)$580.4M
Annual profit (last year)-$738.6M
Net profit margin-127.09%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Jeffrey M. Leiden
SVP &
GM-International Commercial Operations
Simon Bedson
Corporate headquarters
Boston, Massachusetts

Forecasts